14-day Premium Trial Subscription Try For FreeTry Free
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2023 Results Conference Call August 31, 2023 2:30 AM ET Company Participants Sibongakonke N. - Investor Relations Manager Stephen Saad - Chief Execut
Aspen Pharmacare Holdings Limited (OTCPK:APNHF) Q4 2022 Earnings Conference Call September 1, 2022 2:30 AM ET Company Participants Kuseni Dlamini - Chairman Sean Capazorio - Group Chief Financial Offi

New Strong Sell Stocks for July 11th

09:19am, Monday, 11'th Jul 2022
APNHY, AHCHY, and AMK have been added to the Zacks Rank #5 (Strong Sell) List on July 11, 2022.

New Strong Sell Stocks for March 22nd

10:32am, Tuesday, 22'nd Mar 2022
APNHY,BRY, and CSIQ have been added to the Zacks Rank #5 (Strong Sell) List on March 22, 2022.
Aspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call Transcript

Aspen Pharmacare Holdings reports 1H results (OTCMKTS:APNHF)

09:41pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Aspen Pharmacare Holdings press release (APNHF): 1H Normalized headline earnings per share ((NHEPS)) increased 21% to R$8.16
South African drugmaker Aspen Pharmacare on Tuesday concluded an agreement with Johnson & Johnson to package, sell and distribute the American group''s COVID-19 vaccines under its own brand in Africa.

New Strong Sell Stocks for February 28th

10:45am, Monday, 28'th Feb 2022
PRG, AGESY, and APNHY have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2022
US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.
US drug maker Johnson & Johnson says it is close to clinching a vaccine licence deal with South African group Aspen Pharmacare.
A strategic partnership that will enable Aspen Pharmacare to increase production capacity to meet the rising demands for COVID-19 vaccines in Africa. Co-financed by funds from the develoPPP programme of the German Government, digital technologies will enable faster and more efficient production while ensuring consistent product quality. In a joint project, Siemens South Africa, Aspen […] This post first appeared on African Business
The rand, on the up, surprised yesterday as it dipped below the R16 mark as the markets shrugged off the latest developments around the Covid-19 Omicron variant and the record unemployment numbers. Statistics South Africa yesterday revealed that the unemployment rate had escalated to 34.9 percent in the three months to September, the highest level since 2008. Stats SA said 660 000 people lost their jobs during the third quarter, with the number of discouraged work seekers dramatically increasing by 545 000. There are more than 7.6 million people of working age who are unemployed in South Africa. Despite this, the rand made a spectacular recovery following a retreat to R16.21 to the dollar earlier in the day as caution lingered in markets after Omicron sent the world in a panic. After starting the day at R16.11 to the dollar, the rand was unfazed by the unemployment reading, strengthening by 0.22 percent to R15.94 to the greenback by 5pm. Meanwhile, the domestic markets also pushed back against the risk off sentiment that spooked international markets after drugmaker Moderna warned about the Omicron variant.

Aspen SA To Produce Its Own Vaccine

04:59am, Wednesday, 01'st Dec 2021 iAfrica
Aspen Pharmacare has secured a deal with Johnson & Johnson to make and sell a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE